您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览72

Despite demonstration of the superior outcomes of transcatheter aortic valve implantation (TAVI) versus optimal medical therapy for severe left ventricular systolic dysfunction, studies comparing TAVI and surgical aortic valve replacement (AVR) in this high-risk group have been lacking.We performed propensity matching for age, gender, baseline comorbidities, previous interventions, priority at hospital admission, frailty score, New York Heart Association class, EuroSCORE, and associated cardiac diseases. Next, the 30-day mortality and procedure-related morbidity of 162 patients (81 TAVI vs 81 AVR) with severe left ventricular systolic dysfunction (ejection fraction ≤ 35

作者:Francesco, Onorati;Paola, D'Errigo;Claudio, Grossi;Marco, Barbanti;Marco, Ranucci;Daniel Remo, Covello;Stefano, Rosato;Alice, Maraschini;Gennaro, Santoro;Corrado, Tamburino;Fulvia, Seccareccia;Francesco, Santini;Lorenzo, Menicanti

来源:The Journal of thoracic and cardiovascular surgery 2014 年 147卷 2期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:72
作者:
Francesco, Onorati;Paola, D'Errigo;Claudio, Grossi;Marco, Barbanti;Marco, Ranucci;Daniel Remo, Covello;Stefano, Rosato;Alice, Maraschini;Gennaro, Santoro;Corrado, Tamburino;Fulvia, Seccareccia;Francesco, Santini;Lorenzo, Menicanti
来源:
The Journal of thoracic and cardiovascular surgery 2014 年 147卷 2期
标签:
35 35.2 AMI AVR FRANCE-2 French Transcatheter Aortic Valve Intervention ICU ImCU LCOS LVEF PARTNER PPM Placement of AoRTic TraNscathetER SAS SLVSD TAVI VARC Valve Academic Research Consortium acute myocardial infarction aortic valve replacement intensive care unit intermediate care unit left ventricular ejection fraction low cardiac output syndrome permanent pacemaker severe aortic stenosis severe left ventricular systolic dysfunction transcatheter aortic valve implantation
Despite demonstration of the superior outcomes of transcatheter aortic valve implantation (TAVI) versus optimal medical therapy for severe left ventricular systolic dysfunction, studies comparing TAVI and surgical aortic valve replacement (AVR) in this high-risk group have been lacking.We performed propensity matching for age, gender, baseline comorbidities, previous interventions, priority at hospital admission, frailty score, New York Heart Association class, EuroSCORE, and associated cardiac diseases. Next, the 30-day mortality and procedure-related morbidity of 162 patients (81 TAVI vs 81 AVR) with severe left ventricular systolic dysfunction (ejection fraction ≤ 35